MDT

85.26

-0.95%↓

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

Начало・Списък с акции・Heron Therapeutics Inc

Heron Therapeutics Inc

Затворен

СекторЗдравеопазване

1.04 4

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

0.97

Максимум

1.05

Ключови измерители
By Trading Economics
Приходи	15M -3M
Продажби	2.4M 41M
EPS	-0.02
Марж на печалбата	-7.278
Служители	128
EBITDA	13M -792K

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+350% upside

Дивиденти
By Dow Jones
Следващи печалби	5.05.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-47M 171M
Предишно отваряне	-2.96
Предишно затваряне	1.04

Настроения в новините

By Acuity

50%

135 / 348 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Bearish Evidence

2.0001 / 2.42 Подкрепа & съпротива

Heron Therapeutics Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

19.04.2026 г., 23:48 ч. UTC

Значими събития в новините

Crude Oil, Refined Product Prices Moving Higher Amid Renewed Tensions in Strait of Hormuz -- OPIS

19.04.2026 г., 23:36 ч. UTC

Значими събития в новините

NAB Raises Provisions as Australian Banks Face Iran Risks -- Update

19.04.2026 г., 22:47 ч. UTC

Значими събития в новините

National Australia Bank Adds $215 Million in Iran-Driven Credit Provisions

19.04.2026 г., 21:14 ч. UTC

Значими събития в новините

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI Data Due as Focus Remains on Middle East

19.04.2026 г., 21:14 ч. UTC

Значими събития в новините

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI -2-

19.04.2026 г., 23:49 ч. UTC

Пазарно говорене

Значими събития в новините

Gold, Silver Decline Amid Renewed Inflation Concerns -- Market Talk

19.04.2026 г., 23:46 ч. UTC

Пазарно говорене

Nikkei May Rise on Hopes for U.S.-Iran Peace Talks -- Market Talk

19.04.2026 г., 23:38 ч. UTC

Значими събития в новините

U.A.E. Asks U.S. About a Wartime Financial Lifeline -- Update

19.04.2026 г., 23:36 ч. UTC

Пазарно говорене

Значими събития в новините

Oil Climbs on Renewed Tensions Over Strait of Hormuz -- Market Talk

19.04.2026 г., 23:12 ч. UTC

Значими събития в новините

Spot Gold Falls 1.2%, Spot Silver Drops 1.6% on Renewed Middle East Tensions

19.04.2026 г., 23:10 ч. UTC

Значими събития в новините

Front-Month Brent Crude Oil Futures Rise 5.8% to $95.64 per Barrel

19.04.2026 г., 23:09 ч. UTC

Значими събития в новините

Front-Month WTI Crude Oil Futures Climb 7.2% to $89.86 per Barrel

19.04.2026 г., 23:08 ч. UTC

Значими събития в новините

Front-Month Crude Oil Futures Climb on Renewed Tensions Over Strait of Hormuz

19.04.2026 г., 21:20 ч. UTC

Придобивния, сливания и поглъщания

Eli Lilly Nears Deal for Cancer Biotech -- WSJ

19.04.2026 г., 21:20 ч. UTC

Придобивния, сливания и поглъщания

Announcement Could Come As Soon As Monday, Sources Say -- WSJ

19.04.2026 г., 21:20 ч. UTC

Придобивния, сливания и поглъщания

Deal Expected to Be Worth Over $2B Plus Additional Milestones, Sources Say -- WSJ

19.04.2026 г., 21:20 ч. UTC

Придобивния, сливания и поглъщания

Eli Lilly Nears Deal for Kelonia Therapeutics, Sources Say -- WSJ

19.04.2026 г., 20:03 ч. UTC

Значими събития в новините

U.A.E. Central Bank Governor Khaled Mohamed Balama Raised Swap Idea With Treasury Secretary Scott Bessent in Washington -- WSJ

19.04.2026 г., 20:03 ч. UTC

Значими събития в новините

Emiratis Portrayed Swap Proposal as Precautionary and Preliminary in Case Iran War Drags On -- WSJ

19.04.2026 г., 20:03 ч. UTC

Значими събития в новините

The U.A.E. Has Opened Talks with U.S. for Currency Swap -- WSJ

19.04.2026 г., 20:03 ч. UTC

Значими събития в новините

U.A.E. Asks U.S. for a Wartime Financial Lifeline -- WSJ

18.04.2026 г., 01:00 ч. UTC

Значими събития в новините

As Economic Pressures Mount, Will Iran or the U.S. Blink First? -- WSJ

17.04.2026 г., 22:58 ч. UTC

Печалби

Grupo Aeroportuario Del Pacifico: Announces Filing of 2025 Annual Report and Form 20-F

17.04.2026 г., 21:32 ч. UTC

Пазарно говорене

Cerebras IPO Adds to Big Year For AI Firms Going Public -- Market Talk

17.04.2026 г., 21:22 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

17.04.2026 г., 21:22 ч. UTC

Пазарно говорене

Moody's Downgrades Belgium to A1 -- Market Talk

17.04.2026 г., 20:52 ч. UTC

Печалби

Schwab Investors Get Spooked by JPMorgan's AI Strategy. The Big Worry Is Cash Sweeps. -- Barrons.com

17.04.2026 г., 20:50 ч. UTC

Пазарно говорене

Печалби

Придобивния, сливания и поглъщания

Tech, Media & Telecom Roundup: Market Talk

17.04.2026 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

17.04.2026 г., 20:29 ч. UTC

Печалби

These Stocks Are Today's Movers: Royal Caribbean, Dow Inc., Netflix, Intel, Albemarle, Autoliv, Alcoa, and More -- Barrons.com

Сравнение с други в отрасъла

Ценова промяна

Heron Therapeutics Inc Прогноза

Ценова цел

By TipRanks

350% нагоре

12-месечна прогноза

Среден 4.5 USD 350%

Висок 6 USD

Нисък 3 USD

Според 2 анализатори от Wall Street, предложили 12-месечна ценова цел за Heron Therapeutics Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

2 ratings

Купи

Задържане

Продай

Според 2 анализатори, дали борсови рейтинги на Heron Therapeutics Inc през последните 3 месеца.

Техническа оценка

By Trading Central

2.0001 / 2.42Подкрепа & съпротива

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Настроение

By Acuity

135 / 348 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Heron Therapeutics Inc

Heron Therapeutics, Inc., a commercial-stage biotechnology company, focuses on enhancing the lives of patients by developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy. The company is also developing ZYNRELEF, a dual-acting local anesthetic that delivers a fixed-dose combination of the local anesthetic bupivacaine and a low dose of the nonsteroidal anti-inflammatory drug meloxicam; and APONVIE, an intravenous formulation of a substance P/neurokinin-1 receptor antagonist indicated for the prevention of postoperative nausea and vomiting in adults. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in Cary, North Carolina.